India’s pre-wedding boom fuels demand for weight-loss injections despite regulatory concerns
“We understand the curiosity, but this cannot be a quick fix,” said Dr. Swati Pradhan, highlighting concerns over misuse of
Read More
Factual Version of a Story
Eli Lilly
Novo Nordisk and Eli Lilly Reject Claims of Partnership with Mangoceuticals on Obesity Drugs
Novo Nordisk and Eli Lilly clarify that they have no collaboration or special arrangement with telehealth firm Mangoceuticals, following misleading
Read More
Divi’s Laboratories Reports Strong Q2 Growth, Driven by Rising API Demand and Global Expansion
Hyderabad – Indian pharmaceutical giant Divi’s Laboratories outperforms expectations with a surge in profits and strong export performance amid growing
Read More
Eli Lilly’s Mounjaro Becomes India’s Top-Selling Drug, Signaling a New Era in Healthcare Innovation
Hyderabad – Eli Lilly’s groundbreaking weight-loss and diabetes treatment, Mounjaro, takes the top spot in India’s pharmaceutical market, marking a
Read More
U.S. Strikes Breakthrough Deal to Boost Access to Weight-Loss Drugs
A landmark public-private partnership aims to make life-changing obesity and diabetes treatments more affordable and accessible for millions across America.
Read More
Novo Nordisk Nears Completion of Global Restructuring, Poised for Stronger Growth Ahead
Novo Nordisk’s global transformation plan, including the restructuring of its workforce, is nearly complete, signaling the company’s focus on innovation,
Read More
Eli Lilly plans to bring experimental weight-loss pill in India
Mumbai, (Reuters) – Eli Lilly (LLY.N),plans to launch its experimental oral weight-loss drug orforglipron in India, a senior executive said on
Read More